Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FGPLU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,347
Award facts
- Contract value 100% obligated
- $15,346.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,346.55 delivery order to AmerisourceBergen Drug Corp for Cabometyx 40 mg tablets (30-count) on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026.
This delivery order is consistent with AmerisourceBergen's extensive portfolio of federal pharmaceutical supplies delivered through the DLA Medical Supply Chain. Cabometyx, a specialty oncology medication, aligns with the company's demonstrated capability to supply brand-name and specialty pharmaceuticals supporting military healthcare programs and the Defense Health Agency. The delivery order structure and firm fixed pricing reflect the operational flexibility of the prime IDC vehicle, enabling the contractor to fulfill recurring federal medical supply requirements across therapeutic domains. AmerisourceBergen's competitive positioning for federal pharmaceutical procurement is reinforced by the DLA's strategic planning for multiple pharmaceutical prime vendor awards for separate regions under Generation V contracts.
Quick answers
Who was awarded contract SPE2DB25FGPLU?
SPE2DB25FGPLU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FGPLU worth?
The government has obligated $15,347 on SPE2DB25FGPLU.
Is contract SPE2DB25FGPLU an order under another contract?
Yes. SPE2DB25FGPLU is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGPLU competed?
The extent of competition for SPE2DB25FGPLU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award